These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30324143)

  • 41. The contribution of serum hepatitis B virus load in the carcinogenesis and prognosis of hepatocellular carcinoma: evidence from two meta-analyses.
    Chen X; Wu F; Liu Y; Lou J; Zhu B; Zou L; Chen W; Gong J; Wang Y; Zhong R
    Oncotarget; 2016 Aug; 7(31):49299-49309. PubMed ID: 27384478
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk of hepatocellular carcinoma in hepatitis B and D virus co-infected patients: A systematic review and meta-analysis of longitudinal studies.
    Kamal H; Fornes R; Simin J; Stål P; Duberg AS; Brusselaers N; Aleman S
    J Viral Hepat; 2021 Oct; 28(10):1431-1442. PubMed ID: 34291520
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk prediction models for hepatocellular carcinoma in chronic hepatitis B patients on antiviral therapy: A meta-analysis.
    Shen Y; Liu J; Han Z; Jiang W; Cui H; Xun Y
    Clin Res Hepatol Gastroenterol; 2022; 46(6):101930. PubMed ID: 35460902
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incidence of Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regression.
    Orci LA; Sanduzzi-Zamparelli M; Caballol B; Sapena V; Colucci N; Torres F; Bruix J; Reig M; Toso C
    Clin Gastroenterol Hepatol; 2022 Feb; 20(2):283-292.e10. PubMed ID: 33965578
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Meta-analysis and systematic review of prognostic significance of Glypican-3 in patients with hepatitis B-related hepatocellular carcinoma.
    Moudi B; Heidari Z; Mahmoudzadeh-Sagheb H
    Virusdisease; 2019 Jun; 30(2):193-200. PubMed ID: 31179356
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A systematic review and meta-analysis of blood interleukin-4 levels concerning malaria infection and severity.
    Kotepui KU; Thirarattanasunthon P; Rattaprasert P; Kotepui M
    Malar J; 2022 Jul; 21(1):217. PubMed ID: 35820892
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictive value of serum bile acids as metabolite biomarkers for liver cirrhosis: a systematic review and meta-analysis.
    Han X; Wang J; Gu H; Guo H; Cai Y; Liao X; Jiang M
    Metabolomics; 2022 Jun; 18(7):43. PubMed ID: 35759044
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nucleos(t)ide Analogues for Reducing Hepatocellular Carcinoma in Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis.
    Wang X; Liu X; Dang Z; Yu L; Jiang Y; Wang X; Yan Z
    Gut Liver; 2020 Mar; 14(2):232-247. PubMed ID: 31158948
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir Treatment for Chronic Hepatitis B Virus: A Reconstructed Individual Patient Data Meta-analysis.
    Tan DJH; Ng CH; Tay PWL; Syn N; Muthiah MD; Lim WH; Tang ASP; Lim KE; Lim GEH; Tamaki N; Kim BK; Teng MLP; Fung J; Loomba R; Nguyen MH; Huang DQ
    JAMA Netw Open; 2022 Jun; 5(6):e2219407. PubMed ID: 35767258
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship between the rs2596542 polymorphism in the MICA gene promoter and HBV/HCV infection-induced hepatocellular carcinoma: a meta-analysis.
    Luo X; Wang Y; Shen A; Deng H; Ye M
    BMC Med Genet; 2019 Aug; 20(1):142. PubMed ID: 31419949
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Poor adherence to hepatocellular carcinoma surveillance: A systematic review and meta-analysis of a complex issue.
    Zhao C; Jin M; Le RH; Le MH; Chen VL; Jin M; Wong GL; Wong VW; Lim YS; Chuang WL; Yu ML; Nguyen MH
    Liver Int; 2018 Mar; 38(3):503-514. PubMed ID: 28834146
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interleukin-10 gene polymorphisms and hepatocellular carcinoma susceptibility: a meta-analysis.
    Wei YG; Liu F; Li B; Chen X; Ma Y; Yan LN; Wen TF; Xu MQ; Wang WT; Yang JY
    World J Gastroenterol; 2011 Sep; 17(34):3941-7. PubMed ID: 22025883
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic value of plasma fibrinogen in hepatocellular carcinoma: a meta-analysis.
    Huang G; Jiang H; Lin Y; Wu Y; Cai W; Shi B; Luo Y; Jian Z; Zhou X
    Cancer Manag Res; 2018; 10():5027-5041. PubMed ID: 30464603
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative effectiveness of different hepatocellular carcinoma screening intervals or modalities: a systematic review and meta-analysis.
    Yang J; Yang Z; Zeng X; Yu S; Gao L; Jiang Y; Sun F
    Chin Med J (Engl); 2023 Jun; 136(11):1322-1330. PubMed ID: 36921104
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B.
    Hu HH; Liu J; Lin YL; Luo WS; Chu YJ; Chang CL; Jen CL; Lee MH; Lu SN; Wang LY; You SL; Yang HI; Chen CJ;
    Gut; 2016 Sep; 65(9):1514-21. PubMed ID: 26642861
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of interleukin-6 gene polymorphisms with the risk of hepatocellular carcinoma: An up-to-date meta-analysis.
    An PP; Feng LN; Zhang XX; Jin QL
    Medicine (Baltimore); 2020 Dec; 99(50):e23659. PubMed ID: 33327352
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitative assessment of the effect of glutathione S-transferase genes GSTM1 and GSTT1 on hepatocellular carcinoma risk.
    Shen YH; Chen S; Peng YF; Shi YH; Huang XW; Yang GH; Ding ZB; Yi Y; Zhou J; Qiu SJ; Fan J; Ren N
    Tumour Biol; 2014 May; 35(5):4007-15. PubMed ID: 24399650
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TIPS Is Not Associated with a Higher Risk of Developing HCC in Cirrhotic Patients: A Systematic Review and Meta-analysis.
    Chen B; Pang L; Chen HB; Wu DB; Wang YH; Chen EQ
    J Clin Transl Hepatol; 2019 Sep; 7(3):232-237. PubMed ID: 31608215
    [No Abstract]   [Full Text] [Related]  

  • 59. Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta-analysis.
    Campbell C; Wang T; McNaughton AL; Barnes E; Matthews PC
    J Viral Hepat; 2021 Mar; 28(3):493-507. PubMed ID: 33305479
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neutrophil-to-lymphocyte ratio predicts prognosis of patients with hepatocellular carcinoma: a systematic review and meta-analysis.
    Lin S; Hu S; Ran Y; Wu F
    Transl Cancer Res; 2021 Apr; 10(4):1667-1678. PubMed ID: 35116492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.